5 Cancer Research Stories Worth Following – Fall 2017
Recent cancer research stories worth following include a study on post-traumatic stress disorder after a cancer diagnosis.
Exploring progress in cancer research from the patient perspective
Recent cancer research stories worth following include a study on post-traumatic stress disorder after a cancer diagnosis.
Two FDA approvals for immunotherapy treatments highlight cancer research news this summer. But the extremely high costs of new cancer therapies are yet to be addressed.
New clinical trials will test whether the addition of progesterone could improve treatment for hormone receptor-positive breast cancer.
Cancer research stories worth following this spring include a study on the benefits of one type of immune system therapy for patients with metastatic triple negative breast cancer.
Cancer research stories worth following this winter include a possible new use for an existing drug to prevent metastasis in triple negative breast cancer.
Cancer research stories worth following this fall include new developments in targeted treatment for ovarian cancer and for metastatic breast cancer.
Cancer research stories worth following this summer include reports from ASCO on a web app that improves survival for lung cancer patients and a “biosimilar” treatment for the breast cancer drug Herceptin.
Cancer research stories worth following this spring include a potential new combination treatment for HER2-positive breast cancer and evidence that a gene assay may help breast cancer patients avoid unnecessary chemotherapy treatment.
Cancer research stories worth following this winter include an experimental targeted therapy for metastatic triple negative breast cancer and a study on how the financial toxicity of cancer treatment affects physical health and survival.
What progress is being made toward a blood test or “liquid biopsy” to aid in treatment or early detection of breast cancer?